Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment

NCT00574249 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

730

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Plaque Psoriasis

Interventions

BIOLOGICAL: adalimumab
DRUG: Calcipotriol/Betamethasone Ointment
DRUG: placebo (vehicle ointment)

Sponsor

Abbott